Table: Wakamoto Pharm -2020/21 parent results

Wakamoto Pharmaceutical

14/05/2021 07:00

May 14 (Reuters)- 
          Wakamoto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           8.90            10.92          9.10                  
               (-18.5 pct)     (+1.6 pct)                              
  Operating   loss 754 mln    loss 996 mln      60 mln                 
  Recurring   loss 604 mln    loss 911 mln      80 mln                 
  Net         loss 601 mln      loss 1.66       120 mln                
  EPS        loss 17.34 yen  loss 47.73 yen    3.46 yen                
  Ann Div          NIL             NIL                                 
  -Q2 Div          NIL             NIL                                 
  -Q4 Div          NIL             NIL                                 
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T